Clinical and demographic factors determining patient fracture risk decision point (FRDP): the improving risk communication in osteoporosis (RICO) project
Clinical and demographic factors determining patient fracture risk decision point (FRDP): the improving risk communication in osteoporosis (RICO) project
Summary: This study aims to understand how osteoporosis medication acceptance varies across countries with differing guidance on treatment threshold and influence of clinical and demographic factors. A total of 79.2% accepted treatment at a fracture probability at or below the treatment threshold. Fracture history and age did not strongly impact acceptance, suggesting a need for improved fracture risk communication. Purpose: This part of the Improving Risk Communication in Osteoporosis (RICO) study aims to understand patients’ willingness to initiate osteoporosis treatment given a hypothetical fracture probability—derived from the FRAX® Risk Assessment Tool—and how age, fracture history, and numeric literacy may influence this. Methods: In 2022–2023, 332 postmenopausal women at risk of fracture were interviewed from nine countries to determine participants’ Fracture Risk Decision Point (FRDP), the lowest probability of major osteoporotic fracture at which they would accept an osteoporosis medication. Participants’ FRDP was evaluated given eight hypothetical 10-year FRAX scores. Results: In countries with FRAX-based treatment thresholds, over half of the participants per country reported an FRDP that was below the threshold. Collectively, 79.2% demonstrated FRDPs at or below their respective threshold. Age and fracture history did not have a strong influence on FRDP; however, those who demonstrated higher levels of numeric literacy reported a significantly higher median FRDP (10%) compared to those who showed lower levels (5%, p < 0.001). Conclusions: Most patients were willing to accept an osteoporosis medication prescription at a hypothetical FRAX probability that was even lower than that of their nationally recommended treatment threshold. Literacy scores had a significant influence on FRDP whereas age and fracture history did not.
FRAX® probability, Fracture Risk Decision Point (FRDP), Osteoporosis, Patient willingness to accept treatment, Treatment threshold
Sharma, Mitali
2a370135-82ea-4340-81ad-d7e56148b430
Beaudart, Charlotte
bdc9da98-791a-474b-9745-be0695a4d8a9
Clark, Patricia
191bedee-2fe4-4d85-923e-29a8c6680b67
Fujiwara, Saeko
f8f279ea-ad4d-4830-bdf0-a9f61439b619
Adachi, Jonathan D.
5a6456df-b1f8-4423-97d7-6c2811b361e6
Papaioannou, Alexandra
ae7c0579-654b-4cf4-8812-745ff2f0ca6d
Messina, Osvaldo D.
957a619c-76de-4396-96bf-6c716bc6569a
Morin, Suzanne N.
68489af8-f604-4f28-88e0-60add9fde4ae
Kohlmeier, Lynn
e4a5f570-2a0f-48d1-a6f0-3968dae35c9d
Nogués, Xavier
ceeef641-080b-4932-9c4f-1a2a5c73ff6c
Leckie, Carolyn
30c6913a-1661-4a6c-a7c0-d518146a2b10
Harvey, Nicholas C.
ce487fb4-d360-4aac-9d17-9466d6cba145
Kanis, John A.
f1621d8d-8afb-4d97-9679-2165d88a344d
Reginster, Jean-Yves
08b05e27-73dd-4ce9-90e5-d64ec922147a
Hiligsmann, Mickaël
120a5b99-2a0a-4a17-99d1-c0e5147d4f59
Silverman, Stuart L.
f66e4023-8708-449e-b623-dcb63835912e
21 October 2024
Sharma, Mitali
2a370135-82ea-4340-81ad-d7e56148b430
Beaudart, Charlotte
bdc9da98-791a-474b-9745-be0695a4d8a9
Clark, Patricia
191bedee-2fe4-4d85-923e-29a8c6680b67
Fujiwara, Saeko
f8f279ea-ad4d-4830-bdf0-a9f61439b619
Adachi, Jonathan D.
5a6456df-b1f8-4423-97d7-6c2811b361e6
Papaioannou, Alexandra
ae7c0579-654b-4cf4-8812-745ff2f0ca6d
Messina, Osvaldo D.
957a619c-76de-4396-96bf-6c716bc6569a
Morin, Suzanne N.
68489af8-f604-4f28-88e0-60add9fde4ae
Kohlmeier, Lynn
e4a5f570-2a0f-48d1-a6f0-3968dae35c9d
Nogués, Xavier
ceeef641-080b-4932-9c4f-1a2a5c73ff6c
Leckie, Carolyn
30c6913a-1661-4a6c-a7c0-d518146a2b10
Harvey, Nicholas C.
ce487fb4-d360-4aac-9d17-9466d6cba145
Kanis, John A.
f1621d8d-8afb-4d97-9679-2165d88a344d
Reginster, Jean-Yves
08b05e27-73dd-4ce9-90e5-d64ec922147a
Hiligsmann, Mickaël
120a5b99-2a0a-4a17-99d1-c0e5147d4f59
Silverman, Stuart L.
f66e4023-8708-449e-b623-dcb63835912e
Sharma, Mitali, Beaudart, Charlotte, Clark, Patricia, Fujiwara, Saeko, Adachi, Jonathan D., Papaioannou, Alexandra, Messina, Osvaldo D., Morin, Suzanne N., Kohlmeier, Lynn, Nogués, Xavier, Leckie, Carolyn, Harvey, Nicholas C., Kanis, John A., Reginster, Jean-Yves, Hiligsmann, Mickaël and Silverman, Stuart L.
(2024)
Clinical and demographic factors determining patient fracture risk decision point (FRDP): the improving risk communication in osteoporosis (RICO) project.
Osteoporosis International.
(doi:10.1007/s00198-024-07264-5).
Abstract
Summary: This study aims to understand how osteoporosis medication acceptance varies across countries with differing guidance on treatment threshold and influence of clinical and demographic factors. A total of 79.2% accepted treatment at a fracture probability at or below the treatment threshold. Fracture history and age did not strongly impact acceptance, suggesting a need for improved fracture risk communication. Purpose: This part of the Improving Risk Communication in Osteoporosis (RICO) study aims to understand patients’ willingness to initiate osteoporosis treatment given a hypothetical fracture probability—derived from the FRAX® Risk Assessment Tool—and how age, fracture history, and numeric literacy may influence this. Methods: In 2022–2023, 332 postmenopausal women at risk of fracture were interviewed from nine countries to determine participants’ Fracture Risk Decision Point (FRDP), the lowest probability of major osteoporotic fracture at which they would accept an osteoporosis medication. Participants’ FRDP was evaluated given eight hypothetical 10-year FRAX scores. Results: In countries with FRAX-based treatment thresholds, over half of the participants per country reported an FRDP that was below the threshold. Collectively, 79.2% demonstrated FRDPs at or below their respective threshold. Age and fracture history did not have a strong influence on FRDP; however, those who demonstrated higher levels of numeric literacy reported a significantly higher median FRDP (10%) compared to those who showed lower levels (5%, p < 0.001). Conclusions: Most patients were willing to accept an osteoporosis medication prescription at a hypothetical FRAX probability that was even lower than that of their nationally recommended treatment threshold. Literacy scores had a significant influence on FRDP whereas age and fracture history did not.
Text
OSIN-D-24-00546_FINAL
- Accepted Manuscript
Text
s00198-024-07264-5
- Version of Record
More information
Accepted/In Press date: 22 September 2024
e-pub ahead of print date: 21 October 2024
Published date: 21 October 2024
Keywords:
FRAX® probability, Fracture Risk Decision Point (FRDP), Osteoporosis, Patient willingness to accept treatment, Treatment threshold
Identifiers
Local EPrints ID: 495410
URI: http://eprints.soton.ac.uk/id/eprint/495410
ISSN: 0937-941X
PURE UUID: 8bc30997-7012-4ffb-971d-6eb78ef44168
Catalogue record
Date deposited: 13 Nov 2024 17:31
Last modified: 19 Nov 2024 02:39
Export record
Altmetrics
Contributors
Author:
Mitali Sharma
Author:
Charlotte Beaudart
Author:
Patricia Clark
Author:
Saeko Fujiwara
Author:
Jonathan D. Adachi
Author:
Alexandra Papaioannou
Author:
Osvaldo D. Messina
Author:
Suzanne N. Morin
Author:
Lynn Kohlmeier
Author:
Xavier Nogués
Author:
Carolyn Leckie
Author:
John A. Kanis
Author:
Jean-Yves Reginster
Author:
Mickaël Hiligsmann
Author:
Stuart L. Silverman
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics